132 related articles for article (PubMed ID: 2264204)
1. [The effect of heparin on the lipid level during hemodialysis].
Nikolaeva NP; Siniukhin VN; Khokhlov AP; Iarmolinskiĭ IS; Stetsiuk EA
Urol Nefrol (Mosk); 1990; (5):31-3. PubMed ID: 2264204
[TBL] [Abstract][Full Text] [Related]
2. The influence of several factors that intervene in hemodialysis on serum levels of triglycerides and free fatty acids.
Pérez-García A; Bretó M; Alvarińo J; Alegre B; Cruz JM
Clin Nephrol; 1979 Jul; 12(1):14-7. PubMed ID: 477051
[TBL] [Abstract][Full Text] [Related]
3. [Changes in the plasma values of glucose, free fatty acids, triglycerides and cholesterol in terminal kidney failure during hemodialysis].
Romanov N; Shipkova P; Kiriakov Z
Vutr Boles; 1977; 16(4):49-52. PubMed ID: 919513
[TBL] [Abstract][Full Text] [Related]
4. [Changes in serum lipid levels and the spectrum of individual fatty acids in patients with chronic renal failure on conservative and hemodialysis treatment and their relation to dietary protein intake].
Orbetsova V; Simeonov P; Todorov K; Elazarova F
Vutr Boles; 1985; 24(4):63-70. PubMed ID: 4072171
[TBL] [Abstract][Full Text] [Related]
5. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
Gillett MP; Obineche EN; Khan ST; Abdulle AM
Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
[TBL] [Abstract][Full Text] [Related]
6. Lipid abnormalities in chronic renal failure patients undergoing hemodialysis.
de Gómez Dumm NT; Giammona AM; Touceda LA; Raimondi C
Medicina (B Aires); 2001; 61(2):142-6. PubMed ID: 11374135
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic aspects of digoxin in patients with terminal renal failure III. Effect of heparin.
van der Vijgh WJ; Oe PL
Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):560-2. PubMed ID: 598950
[TBL] [Abstract][Full Text] [Related]
8. [Effect of L-carnitine supplementation on lipid metabolism of renal failure, dialysis-dependent children and adolescents].
Böhles H; Michalk D; von Wendt-Göknur E
Infusionstherapie; 1991 Oct; 18(5):224-6. PubMed ID: 1769735
[TBL] [Abstract][Full Text] [Related]
9. [Carbohydrate-lipid metabolism in chronic renal failure. Considerations on some blood lipid parameters examined during conservative and dialysis treatment].
Zuliani U; Novarini A; Bandini L; Borghi L; Canali M; Caronna S; Perinotto P
Minerva Nefrol; 1976; 23(6):423-34. PubMed ID: 1012614
[No Abstract] [Full Text] [Related]
10. The effect of injectable contraceptive on lipid metabolism in women.
Kandeel KM; Nayel SA; Abaza MS
Biomed Biochim Acta; 1984; 43(1):111-5. PubMed ID: 6721873
[TBL] [Abstract][Full Text] [Related]
11. [The effect of cellulose diacetate dialysis membranes on lipids and lipoproteins in uremic patients].
Jakić M; Rupcić V; Stipanić S; Samardzija G; Bilandzija M; Zibar L; Mihaljević D; Milas J
Lijec Vjesn; 1997 Feb; 119(2):56-9. PubMed ID: 9297037
[TBL] [Abstract][Full Text] [Related]
12. [Changes in serum lipid and lipoprotein levels in patients with chronic uremia during hemodialysis treatment].
László A; Csalánosiné Németh M; Joó I; Kiss E; Havass Z; Szenohradszki P
Orv Hetil; 1986 May; 127(19):1129-31. PubMed ID: 3714258
[No Abstract] [Full Text] [Related]
13. [Plasma levels of free fatty acids, triglycerides and cholesterol in acute subrenal kidney failure].
Gyöngyössi G
Acta Chir Acad Sci Hung; 1980; 21(3):245-8. PubMed ID: 7324721
[TBL] [Abstract][Full Text] [Related]
14. [When lipids increase in dialysis: the role of heparin! Standard heparin increases, low-molecular-weight heparin lowers triglycerides].
Wiemer J; Scherberich JE
MMW Fortschr Med; 1999 Oct; 141(43):29-32. PubMed ID: 10912118
[TBL] [Abstract][Full Text] [Related]
15. [Heparin and lipoprotein(a). Observations during hemodialysis].
Salvini P; Maddaloni E; Levi della Vida MV; Parma A; Corpetti MG; Di Lorenzo M
Recenti Prog Med; 1993 Dec; 84(12):828-33. PubMed ID: 8108596
[TBL] [Abstract][Full Text] [Related]
16. [Acute effects of sulodexide on the lipid profile and on antithrombin III in patients with chronic renal insufficiency in hemodialysis treatment].
Averna MR; Citarella P; Picone F; Capodicasa G; Galione A; Rini G; Notarbartolo A
Clin Ter; 1984 Jan; 108(2):111-4. PubMed ID: 6232045
[No Abstract] [Full Text] [Related]
17. [Products of lipid peroxidation in the blood plasma of patients with chronic renal insufficiency treated with hemodialysis].
Nikiforova NV; Sokolovskaia IV
Ter Arkh; 1980; 52(4):55-7. PubMed ID: 7404338
[No Abstract] [Full Text] [Related]
18. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
[TBL] [Abstract][Full Text] [Related]
19. Effects of low molecular weight heparin on the frequencies of intradialytic arrhythmias in hemodialysis patients.
Miyauchi H; Matsumoto Y; Futenma A; Amano I; Miyauchi J; Matsuo S
Ren Fail; 2006; 28(6):469-74. PubMed ID: 16928615
[TBL] [Abstract][Full Text] [Related]
20. Effect of dialysate composition on the lipid response to L-carnitine supplementation.
Zilleruelo G; Novak M; Hsia SL; Goldberg R; Abitbol C; Monkus E; Strauss J
Kidney Int Suppl; 1989 Nov; 27():S259-63. PubMed ID: 2699997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
